Related Experiment Videos
Prostaglandin E2 receptor binding and action in human fat cells
The Journal of Clinical Endocrinology and Metabolism
|July 1, 1984
Summary
Researchers identified the prostaglandin E2 (PGE2) receptor in human fat cells using [3H]PGE2. This receptor mediates the antilipolytic effects of PGE2, impacting fat breakdown.
Area of Science:
- Endocrinology
- Adipocyte Biology
- Molecular Pharmacology
Background:
- Prostaglandin E2 (PGE2) is a key regulator of adipocyte function.
- Understanding PGE2 receptor interactions is crucial for metabolic research.
Purpose of the Study:
- To identify and characterize the prostaglandin E2 (PGE2) receptor in human adipocytes.
- To investigate the role of this receptor in regulating lipolysis.
Main Methods:
- Radioligand binding assays using [3H]PGE2.
- Measurement of basal and isoproterenol-stimulated lipolysis.
- Scatchard analysis to determine binding site characteristics.
Main Results:
- Specific, saturable, and slowly reversible binding of [3H]PGE2 to human adipocytes was observed.
- PGE2 demonstrated antilipolytic effects, with half-maximal inhibition at 3.8 nmol/L (stimulated) and 0.9 nmol/L (basal).
- Scatchard analysis indicated two binding sites with high affinity (Kd = 2 nmol/L) and low affinity (Kd = 56 nmol/L).
Conclusions:
- [3H]PGE2 binds to specific receptors on isolated human adipocytes.
- These receptors mediate the antilipolytic effects of PGE2, influencing fat metabolism.